Objective-To determine the relation between functional capacity and heart rate response to exercise in patients with atrial fibrillation. Subjects-73 consecutive patients with chronic atrial fibrillation. Main outcome measures-Relation between functional capacity, measured as peak oxygen consumption (peak Vo2; mllminlkg), and heart rate at all stages of exercise in univariate and multivariate analyses. Results-Peak 'Vo2 showed no correlation with resting heart rate, but it showed a negative correlation with heart rate during the first stage of exercise (r = -094, p < 0.01). Indeed, heart rate during the early stages of exercise (stages 1-5) was higher in patients with a peak Vo2 less than or equal to 20 mllmmlkg than in those with a peak Vo2 greater than 20 mllminlkg (heart rate 140 v 125 beats/ min, p < 0.05). At maximal exercise, however, peak Vo2 was positively correlated with heart rate (r = 2'15, p < 0.0001).
As early as 1924 Blumgart noted that in patients with atrial fibrillation the initial chronotropic response to exercise was often excessive.' Several studies subsequently confirmed this observation. 24 In patients with congestive heart failure the plasma noradrenaline response is augmented at low levels of exercise and attenuated at maximal exercise.5 6 The chronotropic response to exercise shows a similar pattern in such patients,6 but these studies were performed only in patients with sinus rhythm.
We evaluated the relation between functional capacity and chronotropic responses to exercise in patients with atrial fibrillation. We analysed heart rate responses during exercise testing in a large group of such patients and used univariate and multivariate analysis to delineate the relation between functional capacity, measured as peak oxygen consumption (%,), and heart rate at all levels of exercise. . We determined heart rate at the end of all stages of the exercise protocol on 10 second rhythm strips. Heart rate after standing for two minutes on the treadmill before exercise was considered to be the resting heart rate. As part of routine procedures, blood pressure was measured at rest and at maximal exercise.
Patients and methods

DATA ANALYSIS
To evaluate the correlation of peak \b, with heart rate during exercise we performed stepwise multivariate regression analysis for all stages of the exercise protocol, with heart rate as the dependent variable. Besides peak '°2, several other variables were introduced in the analysis: age, sex, aetiology of atrial fibrillation (including lone atrial fibrillation), and drug treatment (digoxin, calcium antagonists, ,B blockers, amiodarone, and angiotensin converting enzyme inhibitors). To account for the continuity of heart rate at subsequent stages of exercise heart rate at the preceding stage was also included as a variable.
To illustrate the principal findings of the multivariate analysis chronotropic responses of patients with peak %b2 greater than 20 mllmin/kg and peak %2 less than or equal to 20 ml/min/kg were compared. We calculated mean heart rate from stages 1 to 5 to analyse further the difference in chronotropic response at low levels of exercise, as well as mean heart rate at maximal exercise. Also, the mean number of completed stages of the exercise protocol and the mean rise in systolic blood pressure at maximal exercise were determined in these two subsets of patients. To further delineate the importance of possible differences in adrenergic activation chronotropic responses were compared in patients taking only digoxin or calcium antagonists or both orf, blockers, confining the analysis to patients with peak %2 less than or equal to 20 mlmin/kg. Again, mean heart rate from stages 1 to 5 was calculated. Also, clinical characteristics (age, sex, duration and aetiology of atril fibrillation) in these patients were compared. Patients -81 ). The aetiology of atrial fibrillation was valvar heart disease in 27 patients, coronary artery disease in 10, hypertensive heart disease in 11, and miscellaneous in 11 (mainly congenital heart disease and idiopathic dilated cardiomyopathy). In 14 patients no structural cardiac disease was apparent (lone atrial fibrillation). The median duration of atrial fibrillation was 28 (SD 63) months. Drug treatment included digoxin (47 patients), calcium antagonists (verapamil and diltiazem) (22) , f blockers (eight), amiodarone (10), and angiotensin converting enzyme inhibitors (17) . Mean peak %W2 was 19-0 (5 9) mllmin/kg, ranging from 7-4 to 42'2 ml/min/kg. Accordingly, the number of completed stages of exercise varied considerably: 1 to 14 (mean 8). Mean (SD) resting heart rate and mean maximal heart rate were 103 (22) Table 2 shows the results of the multivariate analysis. There was no correlation between peak %2 and resting heart rate. At the first stage of exercise however, there was a significant negative correlation between peak %2 and heart rate: a low peak value correlated with a high heart rate at stage 1 (r = -0.94, p < 0-01). In contrast, maximal heart rate was significantly lower in patients with a low peak %2 (r = 2-15, p < 0 0001). Maximal heart rate was also lower in elderly patients (r= -0 53, p < 0 01). Figure 1 shows the chronotropic responses of 45 patients taking only digoxin or calcium antagonists, or both, comparing 21 patients with peak %2< 20 ml/min/kg and 24 patients with peak b, > 20 ml/min/kg. Although resting heart rate was equal (110 (23) beats/min and 109 (25) beats/min respectively, p > 0-05), patients with impaired functional capacity (peak ;b2 < 20 ml/min/kg) had a higher heart rate at low levels of exercise and a lower heart rate at Stage of exercise Figure 2 Relation between stage ofexerci rate in patients with peak Ao, less than or mllminlkg taking digoxin or calcium antoA (--), or/I blockers (O -0). Verticc Discussion The principal finding of this study is that heart rate at low levels of exercise is augmented and heart rate at maximal exercise attenuated in patients with atrial fibrillation and reduced functional capacity. A relation between impaired functional capacity and nonlinearity of heart rate during exercise in patients with atrial fibrillation was observed previously by Aberg et al3 but they analysed heart rate at only three different workloads and assessed functional capacity by simply -r'r-'-i measuring maximally achieved workload. To 10 12 14 our knowledge, our study is the first to se analyse systematically clinical factors affecting heart rate at low levels of exercise in patients ise and heart with atrial fibrillation. Factors affecting heart than or equal w rate with maximal exercise have been studied ntagonists, or previously. Atwood et al found that maximal heart rate was higher in patients with lone atrial fibrillation than in patients with known rate at low heart disease. Lone atrial fibrillation was also was 140 (24) associated with a higher peak ,b2.4 Our data ectively (p < show that functional capacity is a more powiaximal exer-erful independent predictor of maximal heart ,6) beats/min rate than is the aetiology of atrial fibrillation. 1 also shows In addition, we found age to be independentciated with a ly predictive of maximal heart rate in patients nber of com-with atrial fibrillation as it is in patients with nean number sinus rhythm.'2 1 respectively e in systolic CLINICAL RELEVANCE ially in these Though heart rate at rest (after standing for mm Hg and two minutes on the treadmill before exercise) 0:001).
was controlled,'3 heart rate exceeded 130 beats/min even at the lowest level of exercise iTE in patients with impaired functional capacity t only the use taking only digoxin or calcium antagonists or -ly) with rest-both. Presumably, comparable heart rates are tion, patients attained during normal daily activities. y (peakb2 < Whether tachycardiomyopathy develops -had a lower under such conditions has never been studied evels of exer-prospectively in humans. Reversibility of yoxin or calci-tachycardia induced cardiomyopathy is well Mean heart described, including cardiomyopathy due to 19) and 135 atrial fibrillation, with heart rates as low as ugh numbers 120 beats/min.'1-6 When restoration of sinus respectively), rhythm is not feasible in patients with atrial (p < 0-05). fibrillation, pharmacological treatment with comparable negative dromotropic drugs is aimed at coninical charac-trolling heart rate. In clinical practice dosage of these drugs is titrated on controlling resting heart rate. Though digoxin is reasonably effective in lowering resting heart rate, its value is limited in controlling heart rate even at low levels of exercise.' 1718 The efficacy of calcium antagonists and ,B blockers in controlling heart rate during exercise is comparable, only calcium antagonists (modestly) improving exercise capacity.1921 The relevance of these studies is, however, limited as only patients with (near) normal functional capacity were included and effects on maximal heart rate rather than on heart rate at low levels of exercise were assessed. Our data suggest that /3 blockers may be superior to calcium antagonists and digoxin in controlise and heart ling heart rate at low levels of exercise in 10 may increase exercise capacity and also improve heart rate control.
LIMITATION OF THE STUDY
Our hypothesis was confirmed that in patients with atrial fibrillation and impaired functional capacity the initial heart rate during exercise would be augmented and the maximal heart rate attenuated. However, as noradrenaline concentrations were not measured because of the retrospective design of the study, we were unable to show that these changes in chronotropic response were attributable to similar changes in sympathetic activation during exercise. In this respect, however, the finding that initial heart rate with exercise was not excessive in patients taking fi blockers is interesting. Obviously, as treatment was not randomised, firm conclusions concerning its specific effects cannot be drawn. Nevertheless, we believe this observation supports our hypothesis. This hypothesis is also favoured by the observed systolic blood pressure responses.
